Work

Ctni-48. Neratinib for Nf2 -related Schwannomatosis With Progressive Tumors: Interim Analysis From the Intuitt-nf2 Platform-basket Trial

Year: 2025

Type: conference-abstract

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaf201.0544

Authors: Scott Plotkin, Phioanh Nghiemphu, Kaleb Yohay, Christine Dinh, Vanessa Merker, Geoffrey Fell, Lorenzo Trippa, Jaishri Blakeley

Institutions: Massachusetts General Hospital, University of California, Los Angeles, New York University, University of Miami, Dana-Farber Cancer Institute, Johns Hopkins University

Language: English

Topic: Neurofibromatosis and Schwannoma Cases

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416140476

Cites:

Cited by: 1

Related to: